In contrast to the aforementioned studies, GLI1 was found to play a tumor protective role in mice crossed between GLI1 knockout (GKO) and cre-dependent pancreatic activation of oncogenic KRAS with concomitant loss of the tumor suppressor tp53 (KPC). This evidence concerns the gene KRAS and neoplasm.